Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infections
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infections
Authors
Keywords
AMR, CRAB, Rifabutin, Intravenous, BV100, Drug development
Journal
DRUG DISCOVERY TODAY
Volume 26, Issue 9, Pages 2099-2104
Publisher
Elsevier BV
Online
2021-07-06
DOI
10.1016/j.drudis.2021.07.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic rifabutin and colistin reduce emergence of resistance when treating Acinetobacter baumannii
- (2021) Jiaqi Cheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii
- (2020) Brian Luna et al. Nature Microbiology
- In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms
- (2020) Vincent Trebosc et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Pharmacology, Dosing, and Side Effects of Rifabutin as a Possible Therapy for Antibiotic-Resistant Acinetobacter Infections
- (2020) M C Phillips et al. Open Forum Infectious Diseases
- Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
- (2019) Ana C Gales et al. Open Forum Infectious Diseases
- Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis
- (2019) Xingran Du et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Safety and efficacy of colistin alone or in combination in adults with Acinetobacter baumannii infection: a systematic review and meta-analysis
- (2018) Jin Wang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
- (2018) Alessandro Cassini et al. LANCET INFECTIOUS DISEASES
- Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition
- (2017) Wei Lin et al. MOLECULAR CELL
- The Accidental Orthodoxy of Drs. Mueller and Hinton
- (2017) Victor Nizet EBioMedicine
- Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens
- (2015) Leo Lin et al. EBioMedicine
- X-ray Crystal Structures of the Escherichia coli RNA Polymerase in Complex with Benzoxazinorifamycins
- (2013) Vadim Molodtsov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation
- (2013) Soumaya Zlitni et al. Nature Chemical Biology
- Identification and Characterization of an Outer Membrane Receptor Gene in Acinetobacter baumannii Required for Utilization of Desferricoprogen, Rhodotorulic Acid, and Desferrioxamine B as Xenosiderophores
- (2012) Tatsuya Funahashi et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Increased Susceptibility of Pseudomonas aeruginosa to Macrolides and Ketolides in Eukaryotic Cell Culture Media and Biological Fluids Due to Decreased Expression of oprM and Increased Outer-Membrane Permeability
- (2012) Julien M. Buyck et al. CLINICAL INFECTIOUS DISEASES
- Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy
- (2011) Maria Giannouli et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- TonB-Dependent Transporters: Regulation, Structure, and Function
- (2010) Nicholas Noinaj et al. Annual Review of Microbiology
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Rifamycins do not function by allosteric modulation of binding of Mg2+ to the RNA polymerase active center
- (2008) A. Feklistov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started